全文获取类型
收费全文 | 3239570篇 |
免费 | 269303篇 |
国内免费 | 13742篇 |
专业分类
耳鼻咽喉 | 44259篇 |
儿科学 | 103841篇 |
妇产科学 | 82900篇 |
基础医学 | 521794篇 |
口腔科学 | 86996篇 |
临床医学 | 291538篇 |
内科学 | 564402篇 |
皮肤病学 | 88337篇 |
神经病学 | 279000篇 |
特种医学 | 127375篇 |
外国民族医学 | 329篇 |
外科学 | 501207篇 |
综合类 | 100648篇 |
现状与发展 | 23篇 |
一般理论 | 2263篇 |
预防医学 | 274384篇 |
眼科学 | 73849篇 |
药学 | 220373篇 |
23篇 | |
中国医学 | 9313篇 |
肿瘤学 | 149761篇 |
出版年
2021年 | 54832篇 |
2020年 | 35008篇 |
2019年 | 57937篇 |
2018年 | 70748篇 |
2017年 | 53991篇 |
2016年 | 59570篇 |
2015年 | 73715篇 |
2014年 | 107875篇 |
2013年 | 173121篇 |
2012年 | 86679篇 |
2011年 | 86197篇 |
2010年 | 115275篇 |
2009年 | 120006篇 |
2008年 | 73272篇 |
2007年 | 75426篇 |
2006年 | 86587篇 |
2005年 | 81874篇 |
2004年 | 84197篇 |
2003年 | 75224篇 |
2002年 | 64987篇 |
2001年 | 94405篇 |
2000年 | 86941篇 |
1999年 | 88646篇 |
1998年 | 64298篇 |
1997年 | 62353篇 |
1996年 | 60119篇 |
1995年 | 55663篇 |
1994年 | 49935篇 |
1993年 | 46504篇 |
1992年 | 62341篇 |
1991年 | 59456篇 |
1990年 | 56558篇 |
1989年 | 55936篇 |
1988年 | 51596篇 |
1987年 | 51012篇 |
1986年 | 48118篇 |
1985年 | 48636篇 |
1984年 | 45273篇 |
1983年 | 41546篇 |
1982年 | 40683篇 |
1981年 | 38493篇 |
1980年 | 36196篇 |
1979年 | 37050篇 |
1978年 | 33747篇 |
1977年 | 30955篇 |
1976年 | 28456篇 |
1975年 | 26800篇 |
1974年 | 27568篇 |
1973年 | 26527篇 |
1972年 | 24642篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
961.
962.
963.
Theodore C. Bania MD MS Tom Ashar MD Gregory Press MD Patricia M. Carey MD 《Academic emergency medicine》2003,10(7):697-704
Long-term daily use of gamma-hydroxybutyrate (GHB) and related compounds has recently been associated with a withdrawal syndrome. To the best of the authors' knowledge, there are currently no animal models of GHB withdrawal. OBJECTIVES: The authors studied and described the effect of chronic dosing of GHB (3-6 days) on tolerance and withdrawal in a rat model. METHODS: Rats were administered GHB every three hours via intraperitoneal catheter. Groups of rats (2 per group) were dosed with GHB for either 3 (24 doses), 4 (32 doses), 5 (40 doses), or 6 (48 doses) days. The GHB dose was 0.25 g/kg for doses 1-8, 0.75 g/kg for doses 9-12, 1 g/kg for doses 13-16, 1.25 g/kg for doses 17-24, 1.5 g/kg for doses 25-32, 1.75 g/kg for doses 33-40, and 2 g/kg for doses 41-48. Following the last dose of GHB, the rats were scored using a 16-point ethanol intoxication-withdrawal scale rating spontaneous behaviors, response to handling, grooming, and neurological signs. Lower scores indicate intoxication, while higher scores indicate withdrawal. Scores were recorded at hours 0, 1, 2, 3, 4, 5, 6, 9, 12, and 24. RESULTS: Tolerance: Rats dosed with GHB for more days were less intoxicated one hour after their last GHB dose despite receiving higher doses. WITHDRAWAL: The scores for all rats dosed with GHB increased at hours 4 (p = 0.028), 5 (p = 0.037), 6 (p = 0.007), and 9 (p = 0.024) after the last dose, indicating withdrawal. The scores demonstrated a linear increase dependent upon the number of days of GHB dosing at hours 3 (p < 0.000), 4 (p = 0.004), 5 (p = 0.002), and 12 (p = 0.039) as well as prior to the last dose at hour 0 (p = 0.000). No rats developed seizures. CONCLUSIONS: Tolerance and mild withdrawal in rats can be induced by administering intraperitoneal GHB every three hours for 3-6 days. More prolonged dosing and higher doses of GHB may be necessary to induce severe withdrawal. 相似文献
964.
965.
Ayad Al Darrab Jerome Fan Christopher M B Fernandes Rosanne Zimmerman Rhonda Smith Andrew Worster Teresa Smith Kelly O'Connor 《European journal of emergency medicine》2006,13(1):32-35
STUDY OBJECTIVES: Use of fast track has been shown to improve the emergency department flow of less urgent patients. It has been speculated, however, that this could negatively affect the care of urgent patients. The objective of this study was to determine whether a dedicated fast track for less urgent patients [Canadian Triage and Acuity scale category 4/5 (CTAS 4/5)] affected (1) the time to assessment for urgent patients (CTAS 3), (2) the length of stay for less urgent patients (CTAS 4 and 5), and (3) the left-without-being-seen rate. METHODS: In June 2003, fast track was opened in our emergency department from 13:00 to 19:00 h. A before-after intervention comparison analysis was completed for 1 week in Aug 2002 and the same week in Aug 2003. Data collected included (1) time to assessment of CTAS 3 patients, (2) the length of stay for CTAS 4/5 patients, and (3) percentage of patients who left without being seen. RESULTS: A total of 368 patients were reviewed for 2002 and 380 patients were reviewed for 2003. Median time to assessment of CTAS 3 patients presenting from 13:00 to 19:00 h was reduced from 66 min (Interquartile range: 40, 94 min) in 2002 to 60 min (IQR: 38, 108 min) after fast track was open in 2003 (P = 0.95). Median length of stay of CTAS 4 and 5 patients was reduced from 170 min (IQR: 111, 256 min) to 110 min (IQR: 69, 185 min) (P < 0.001). The overall left-without-being-seen rate decreased from 5% (20/368) to 2% (9/380). CONCLUSION: A dedicated fast track for CTAS 4/5 patients can reduce the length of stay and the left-without-being-seen rate with no impact on CTAS 3 patients seen in the main emergency department. 相似文献
966.
967.
Lei Li Jürgen Bruns Reinhard E. Friedrich Rainer Schmelzle 《European journal of plastic surgery》2006,29(2):93-96
Adamantinoma of long bones is one of the rarest of malignant bone tumors; it is commonly located in the middle or lower third of the diaphysis of the tibia. A case with multiple occurrences affecting both the tibia and fibula is presented. En bloc resection with wide operative margins was performed, and a large tibial defect of 23 cm was effectively bridged by a revascularized free fibular flap. At 13 months follow-up, there was no sign of local recurrence or metastasis, and the patient was mobile. 相似文献
968.
969.
目的 探讨Lugol液染色对食管早期癌和癌前病变的诊断价值。方法 对45例食管黏膜可疑病变经内镜以2%Lugol液喷洒染色,观察黏膜染色情况,并取活检送病理组织学检查。结果 45例食管病变染色后,39例呈浅染色或不染色,其中食管癌8例(食管早期癌5例,进展期癌3例),Barrett食管5例,轻至中度不典型增生1l例。本组Lugol液染色对食管早期癌和癌前病变的检出率达46.7%。结论 内镜下应用Lugol液染色结合活检有助于食管早期癌和癌前病变的诊断,且操作简便,具有重要的临床价值。 相似文献
970.